Client: Bluestar Adisseo
Acquisition of Framelco Group by Bluestar Adisseo
Adisseo announces the signature of an agreement for the acquisition of FRAmelco Group
Bluestar Adisseo Company (“Adisseo”) announces the signature of an agreement to acquire FRAmelco Group, a Dutch feed additive company (meaning FRAnklin Group BV and its wholly owned subsidiaries – hereafter “FRAmelco”). This transaction is part of Adisseo’s strategy to boost Specialties growth to become one of the worldwide leaders of specialty feed ingredients in animal nutrition. This acquisition will reinforce Adisseo’s position in the promising Health by Nutrition market segment.
FRAmelco Group, a family owned multinational group headquartered in The Netherlands, operates 3 plants located in The Netherlands, Spain, and Thailand. The business generates gross sales of about €30 million per year. Most of FRAmelco sales are made of Glycerides (short and medium chain fatty acids) to maintain animal in good health and to improve animal performance and Lysolecithins to improve feed digestibility. FRAmelco’s industrial footprint, its product range, its technologies, the species addressed, and its target markets are highly complementary to Adisseo’s. It will allow the combined business to implement integrated solutions and offer even more value to customers who want to reduce antibiotic usage and enhance animal resilience.
Commenting on the acquisition, Jean-Marc Dublanc, CEO of Adisseo, said:
“Today we take another step forward in implementing our growth strategy on Specialties. We look forward to welcoming the FRAmelco management and employees with their great knowledge and expertise. The acquisition of FRAmelco is bringing products, solutions, and know-hows to better address our customers’ current and future needs. Together, we will set up an efficient organization which will allow us to strengthen our global product portfolio’s competitiveness. We will become the leader in short and medium chain fatty acids, a promising technology which fits perfectly with our vision of contributing to healthier animals through nutrition. We will also mutually benefit from respective strengths and global commercial coverage to better serve customers and capture market growth.”.
Lars Snijders, CEO of FRAmelco added:
“We are excited to become part of Adisseo because both companies are driven by the same ambition – to deliver the most innovative and sustainable feed solutions to customers. We are proud of what we have achieved in recent years, bringing solutions and value to our clients through our Glycerides and Lysolecithins technologies. By combining our strengths with those of Adisseo, we can jointly accelerate success.”
Adisseo is one of the world’s leading experts in feed additives.
The group relies on its 10 research centers and its production sites based in Europe, USA, and China to design, produce and market nutritional solutions for sustainable animal feed. With more than 2,250 employees, it serves around 3,900 customers in over 110 different countries through its global distribution network. In 2019, Adisseo achieved a turnover of over 1.44 billion Euros.
Adisseo is one of the main subsidiaries of China National BlueStar, leader in the Chinese chemical industry with nearly 21,000 employees and a turnover of 6,8 billion USD.
Adisseo is listed on the Shanghai Stock Exchange.
FRAmelco is specialized in the development, manufacturing and marketing of feed and drinking water additives worldwide. It provides the industry with additive solutions that allow both agriculture and aquaculture to increase productivity and profitability in a sustainable manner.
Production of Glycerides and Lysolecithins are carried out in-house in three different production units, the Netherlands, Spain, and Thailand.
The group employs 75 persons, is active in over 60 countries and expands rapidly.
8 September 2020 (Announcement date)
Client: Bluestar Adisseo Company
Target: Framelco Group
Buyer: Bluestar Adisseo Company
Seller: Founding family